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CASE REPORT
INTRODUCTION
Esophageal tumor are often found by chance during
endoscopy or radiologic examination. Benign epithelial
tumors in the esophagus can take the form of squamous
papilloma or adenoma, whild benign non-epithelial tumors
found in the esophagus include leiomyomas,
hamartomas, fibromas, lypomas, lymphangiomas,
granullar tumor cells and fibrovascular polyps.1
Squamous papillomatous tumors are associated with
chronic irritation and reflux esophagitis. They are
usually cecile, polypoid, and located at the 1/3 distal
esophagus.2
The pathologic findings of reflux esophagitis include
hightened papilla and basal cell hyperplasia. Elongation
of the papilla occurs due to destruction of the cell
surface by acids, while basal cell hyperplasia
demonstrate accelerated basal cell replication rate. Acute
inflammation, characterized by infiltration of
polymorphonuclear cells, is specific for esophagitis.3
In general, the management of reflux esophagitis
includes life style modification and medication. Life style
modification include cessation of smoking; cessation of
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ABSTRACT
Esophageal polyp can be found by chance during endoscopic examination. Polyps can be formed by
changes in the esophageal mucosa due to reflux esophagitis. We report a case of multiple esophageal polyp
in a patient with complaints of recurrent regurgitation without heartburn. Endoscopy demonstrated multiple
polyps at the distal esophagus. Anatomic pathology evaluation of the polyp demonstrated mucosa lined with
squamous epithels demonstrating elongation of the papilla and deposition of acute and chronic
inflammatory cells, indicating chronic esophagitis with hyperplastic epithels. In this case, we conducted
recurrent ligation of the multiple polyps. Evaluation at 2 weeks after the final ligation demonstrated no
polyp remains, and the post-ligation ulcer was found. Evaluation at 1 month following treatment found
diminished complaints. From this case, we can conclude that endoscopy is an important investigation
modality to establish the diagnosis in cases of chronic gastrointestinal complaints. Ligation is a choice for
the management of esophageal polyps.
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alcohol consumption; reduction of fatty foods, tomato
and citrus juices, coffee, tea, and soda drinks; avoiding
prior to bedtime snacking; as well as weight reduction
for overweight patients. Medications include antacids,
mucoprotector agents (sucralphate), H2 antagonist
receptors, proton-pump inhibitors, and prokinetic agents.
If reflux esophagitis has caused changes in the mucosa
in the form of polyps, polypectomy may be performed.
We report a case of esphageal polyp found by chance
during endoscopy due to complaints of dyspepsia with-
out clear complaints of reflux esophagitis.
CASE REPORT
The patient was a 55 year-old male who came with
complaints of recurrent epigastric discomfort, unrelated
to meals, as well as acidic taste rising to the mouth,
nausea, and gassiness. The patient denied any feeling of
heartburn. The patient reported recurrent mouth ulcer.
He denied any weight loss or changes in defecation
pattern. The problem has occurred since 1 year prior to
evaluation. The patient had taken antacids, ranitidine.
Complaints lessened as the patient took the medication,
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and reappeared when he ran out of medication.
He denied history of hepatitis, diabetes, and heart
disease. During physical examination, his heart and lung
were within normal limits. During abdominal
examination, the abdomen, liver, and spleen were not
palpable.
See Table 1 for reports of laboratory findings.
conducted 2 weeks following ligation, demonstrating
ulcer at the location of ligation and no more polyp. The
patient was treated with 2 x 20 mg of omeprazole for 1
week, followed by 1 x 20 mg for the following three
weekw, and 1 x 15 cc of fluid sucralphate. During 1
month control after polyp ligation, the complaint of pain
had decreased.
DISCUSSION
Esophageal polyp is a rare case. It is usually found
by chance during endoscopy. Polyps are formed due to
changes in the esophageal mucosa due to reflux
esophagitis. The incidence of esophagitis varies greatly.
A study in Cipto Mangunkusumo Hospital found 22.8%
cases of esophagitis out of 30 cases of dyspepsia in the
year 1998.4 Another study in the same hospital
Figure 2.  Ligation of the esophageal polyp using local multiple ligators.
Figure 3.  Esophagoscopy demonstrating post-ligation ulcer and
no more polyp 2  weeks following the final ligation.
Table 1. Results of Routine Laboratory Evaluation 
Evaluation Results 
Hemoglobin level 12,3 g/dl 
Leukocyte count 12.200 /ul 
Platelet count 396.000/ul 
SGOT 34 U/l 
SGPT 23 U/l 
Cito blood sugar 100 mg/dl 
Complete stool evaluation Within normal limits 
  
Figure 1.  Endoscopy of the upper gastrointestinal tract,
demonstrating multiple polyps of the esophagus.
Endoscopy of the upper gastrointestinal tract
demonstrated multiple polyps and moderate erosive
gastritis. Histopathologic evaluation of the gaster dem-
onstrated moderate distribution of mononuclear cells, no
polymorphonuclear cells, no intestinal metaplasia, mild
glandular atrophy, and no helicobacter pylori.
Histopathologic evaluation of the polyp demonstrated
mucosa lined with squamous epithel demonstrating
elongation of the papilla and submucosal deposition of
acute and chronic inflammatory cells, indicating
esophagitis. Repeat histologic evaluation of the
esophageal polyp demonstrated chronic esophagitis with
hyperplastic epithels, and no signs of malignancy.
The polyp was ligated twice with a time interval of 2
weeks. Post-ligation endoscopic evaluation was
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demonstrated that almost 96.88% of cases of reflux type
dyspepsia were diagnosed as esophagitis according to
anatomic pathology evaluation.5 The diagnosis of reflux
esophagitis is established if there are complaints of
regurgitation and heartburn, dysphagia, odinophagia, and
burping.6  Another study by Juwanto in cases of
complaints of  reflux esophagitis found 25 out of 32 cases
demonstrating signs of esophagitis during endoscopy.4
In this case, the patient came with complaints of
reflux esophagitis, and endoscopic evaluation discovered
an esophageal polyp. Pathologic anatomy examination
indicated chronic esophagitis. This data demonstrated
that the polyp is a hyperplastic polyp due to esophagitis.
Other complications that can occur due to reflux
esophagitis may be mild to severe chronic cough,
bronchial asthma, vocal cord disorder, stricture, Baret’s
esophagus, bleeding, and even perforation.3 Bearing in
mind the possible complications, early endoscopic
diagnosis must be established in patients with complaints
of reflux esophagitis.
At the moment, reflux esophagitis is classified as a
gastroesophageal reflux disease (GERD). The main goal
in the treatment of the disease is to eliminate symptoms
rapidly and effectively. The secondary goal is to heal
erosion and ulceration, and thus preventing
complications.7 The best management strategy for GERD
is the step-down treatment approach, starting with the
strongest anti-acid agent (proton-pump inhibitors) and
gradually stepping down by reducing the dose and
replacing it with H2 antagonists.8 Presently, a new
proton-pump inhibitor, esomeprazole, is being marketed
in several countries. The drug is said to have a stronger
control on gastric acid within 24 hours, thus expected to
be more effective in the management of GERD in the
future.9
The management of this patient included serial
ligation until the polyp is eliminated. Evaluation at 1 month
following the final treatment demonstrated no signs of
the polyp. Aside from therapeutic endoscopy, the
patient received omeprazole for 1 month, with an initial
dose of 2 x 20 mg, then reduced to 1 x 20 mg.
Complaints of reflux esophagitis gradually diminished
after ligation and treatment with proton-pump inhibitors.
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